Published: 1 April, 2026
Early learning from the DETECT VTE tool, developed by Thrombosis UK and piloted by gtd healthcare, is shaping how venous thromboembolism is identified in primary care.
The pilot is being delivered across all gtd healthcare GP practices, supporting clinicians to assess venous thromboembolism risk during consultations. Following the first phase of the pilot, representatives from Thrombosis UK, including Professor Beverley Hunt OBE, medical director, and Oberoi Consulting, met with colleagues from gtd healthcare to discuss how the tool is being used and how it is supporting clinical practice.
Sharon Collins, venous thromboembolism lead, said it was a productive meeting, which enabled us to reflect on the progress made so far with our national partners.
“It has been encouraging to see how technology can support clinicians to consider venous thromboembolism risk earlier in the patient journey,” she said.
“We explored what the tool is telling us about venous thromboembolism risk in our patient populations and how it aids decision-making.
“We also discussed some of the challenges encountered and shared constructive feedback to help refine and enhance the system.
“This pilot presents a fantastic opportunity, as the learning from our practices will help shape the future development and potential national rollout of the tool.”
The DETECT VTE tool, which is embedded within EMIS, was developed by Thrombosis UK in partnership with Oberoi Consulting following two years of work to improve venous thromboembolism detection in primary care. It includes pop-up alerts prompting clinicians to Think VTE, consultation templates to support clinical assessment and quality improvement searches that highlight patients who may require further review.
To find out more about the pilot, please email sharon.collins18@nhs.net or gtd.corporateaffairs@nhs.net.
